Literature DB >> 19064575

Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.

Lauren P Wallner1, Aruna V Sarma, Michael M Lieber, Jennifer L St Sauver, Debra J Jacobson, Michaela E McGree, Monica E Gowan, Steven J Jacobsen.   

Abstract

Prostate cancer is the second leading cause of cancer deaths among U.S. men. Early detection is associated with drastically improved 5-year survival rates. It is unclear, however, what psychosocial factors motivate or discourage men from taking advantage of both prostate-specific antigen (PSA) testing and digital rectal examination (DRE). The goal of the current study was to identify psychosocial factors that influence screening behavior for prostate cancer in a cohort of 2,447 men. In 1990, a randomly selected cohort of Caucasian men, ages 40 to 79 years, from Olmsted County, Minnesota, were enrolled in the study. These men completed a questionnaire containing queries on family history of prostate cancer, concern about getting prostate cancer, and marital status. Medical and laboratory records were reviewed to determine the number DREs (1989-1996) and PSA tests (1989-1998). Frequent screening was defined as the upper 25th percentile for number of DREs (>4) or PSAs (>3). Men who have a family history and men who worry or have concern about prostate cancer were more likely [odds ratio (OR), 1.5; 95% confidence interval (95% CI), 1.2-2.0 and OR, 1.9; 95% CI, 1.4-2.5] to seek screening compared with those without a family history or worry. The association between family history and frequent screening was similar in men who were married or living with someone (OR, 1.7; 95% CI, 1.2-2.2); however, it was reduced among men who live alone (OR, 0.6; 95% CI, 0.2-1.8). These data suggest that psychosocial factors such as family history, worry, or concern about prostate cancer and marital status may play an important role in men's decisions about prostate cancer screening.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064575      PMCID: PMC2662441          DOI: 10.1158/1055-9965.EPI-08-0050

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.

Authors:  R M Merrill
Journal:  Prev Med       Date:  2001-12       Impact factor: 4.018

2.  Factors influencing use of the prostate-specific antigen screening test in primary care.

Authors:  W P Moran; S J Cohen; J S Preisser; J L Wofford; B J Shelton; M W McClatchey
Journal:  Am J Manag Care       Date:  2000-03       Impact factor: 2.229

3.  Two distinct groups of non-attenders in an organized mammography screening program.

Authors:  A R Aro; H J de Koning; P Absetz; M Schreck
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

4.  Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.

Authors:  Bettina Meiser; Ruth Cowan; Anthony Costello; Graham G Giles; Geoff J Lindeman; Clara L Gaff
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

5.  Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.

Authors:  Jennifer L Beebe-Dimmer; David P Wood; Stephen B Gruber; Julie A Douglas; Joseph D Bonner; Caroline Mohai; Kimberly A Zuhlke; Cassandra Shepherd; Kathleen A Cooney
Journal:  Urology       Date:  2004-02       Impact factor: 2.649

6.  A focus group study of factors influencing African-American men's prostate cancer screening behavior.

Authors:  Folakemi T Odedina; John Scrivens; Angela Emanuel; Margareth LaRose-Pierre; James Brown; Rowena Nash
Journal:  J Natl Med Assoc       Date:  2004-06       Impact factor: 1.798

7.  Relation of family history of prostate cancer to perceived vulnerability and screening behavior.

Authors:  Paul B Jacobsen; Laurie A Lamonde; Melissa Honour; Kathryn Kash; Perry B Hudson; Julio Pow-Sang
Journal:  Psychooncology       Date:  2004-02       Impact factor: 3.894

Review 8.  Epidemiology of prostate cancer.

Authors:  E David Crawford
Journal:  Urology       Date:  2003-12-22       Impact factor: 2.649

9.  Behaviors used by men to protect themselves against prostate cancer.

Authors:  Elisabeth J S Kunkel; Birgit Meyer; Constantine Daskalakis; James Cocroft; Kathleen Jennings-Dozier; Ronald E Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

10.  Risk perception and concern among brothers of men with prostate carcinoma.

Authors:  Jennifer L Beebe-Dimmer; David P Wood; Stephen B Gruber; Doug M Chilson; Kimberly A Zuhlke; Gina B Claeys; Kathleen A Cooney
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860

View more
  15 in total

1.  The association between statin use and the diagnosis of prostate cancer in a population based cohort.

Authors:  Rodney H Breau; R Jeffrey Karnes; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen; Ajay Nehra; Michael M Lieber; Jennifer L St Sauver
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

2.  The Effects of Population-based Prostate-specific Antigen Screening Beginning at Age 40.

Authors:  Christopher J Weight; Vikram M Narayan; Daniel Smith; Simon P Kim; R Jeffrey Karnes
Journal:  Urology       Date:  2017-08-24       Impact factor: 2.649

3.  Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors.

Authors:  Andreas Dinkel; Marielouise Kornmayer; Jürgen E Gschwend; Birgitt Marten-Mittag; Peter Herschbach; Kathleen Herkommer
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

4.  Cancer information scanning and seeking in the general population.

Authors:  Bridget Kelly; Robert Hornik; Anca Romantan; J Sanford Schwartz; Katrina Armstrong; Angela DeMichele; Martin Fishbein; Stacy Gray; Shawnika Hull; Annice Kim; Rebekah Nagler; Jeff Niederdeppe; A Susana Ramírez; Aaron Smith-McLallen; Norman Wong
Journal:  J Health Commun       Date:  2010-10

5.  Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.

Authors:  Jeanne M Ferrante; Eric K Shaw; John G Scott
Journal:  J Community Health       Date:  2011-10

6.  The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.

Authors:  Mohammed Nabhan; Simon P Kim; Nilay D Shah; Stephanie M Bagniewski; Qian Shi; R Jeffrey Karnes; Christopher J Weight; Brian J Davis; Manish Kohli; Jon C Tilburt
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

7.  Prostate cancer screening and health care system distrust in Philadelphia.

Authors:  Tse-Chuan Yang; Stephen A Matthews; Roger T Anderson
Journal:  J Aging Health       Date:  2013-06-16

8.  Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias.

Authors:  Takahiro Tabuchi; Tomio Nakayama; Wakaba Fukushima; Ichiro Matsunaga; Satoko Ohfuji; Kyoko Kondo; Eiji Kawano; Hiroyuki Fukuhara; Yuri Ito; Akira Oshima
Journal:  Cancer Sci       Date:  2014-12-03       Impact factor: 6.716

9.  Predictors of patient uptake of colorectal cancer gene environment risk assessment.

Authors:  Michael J Hall; Sharon L Manne; Ronald E Myers; Eileen M Keenan; Andrew M Balshem; David S Weinberg
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

10.  Prognostic significance of cancer family history for patients with gastric cancer: a single center experience from China.

Authors:  Xiaowen Liu; Hong Cai; Lin Yu; Hua Huang; Ziwen Long; Yanong Wang
Journal:  Oncotarget       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.